Dosage Forms in Drug Delivery: State of the Art and Future Perspectives
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 124
Special Issue Editor
Interests: nanomedicine; cancer; controlled release systems; prosthetic infection; microparticles
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The design and optimization of dosage forms play a pivotal role in drug delivery. These dosage forms are very varied, including oral dosage forms (e.g., tablets or capsules), injectable dosage forms (e.g., microparticles, implants, nanoparticles, or liposomes), and topical dosage forms (e.g., patches). These formulations have a significant impact on absorption, distribution, and patient compliance. This Special Issue, entitled "Dosage Forms in Drug Delivery: State of the Art and Future Perspectives", aims to provide an in-depth examination of the latest advancements and emerging trends in dosage form design and their implications for drug delivery. It will cover a wide range of topics, including novel formulation approaches, biopharmaceutical considerations, and the use of advanced materials and technologies to enhance drug release, stability, and targeting. The purpose of this Special Issue is to present cutting-edge research and innovations in dosage form design and development, highlighting both current practices and future trends. By bringing together leading experts and emerging voices in the field, this Special Issue aims to foster advancements in formulation science and enhance the precision and effectiveness of drug delivery systems.
We look forward to receiving your contributions.
Dr. Cristina Martín-Sabroso
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dosage forms
- drug delivery
- tablets
- capsules
- nanoparticles
- liposomes
- patches
- microparticles
- implants
- therapeutic efficacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
